コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 , manganese intoxication in intravenous drug abusers).
2 experience that is keenly sought by ketamine abusers.
3 croglial activation in human methamphetamine abusers.
4 ug craving observed in human psychostimulant abusers.
5 ted in 39 comparison subjects and 39 cocaine abusers.
6 control, attention and vigilance in cocaine abusers.
7 so increased, particularly among amphetamine abusers.
8 cific guidelines for assessment of substance abusers.
9 regions (e.g., prefrontal cortices) in drug abusers.
10 increased the risk for cirrhosis in alcohol abusers.
11 ation responses between controls and cocaine abusers.
12 and anhedonia in detoxified methamphetamine abusers.
13 stimulant drug methylphenidate in 25 cocaine abusers.
14 rget and provide care to the youngest heroin abusers.
15 ain dopamine (DA) neurons of chronic cocaine abusers.
16 relative strengths on a vigilance task among abusers.
17 Two thirds were homeless and/or substance abusers.
18 within the dopamine neurons of human cocaine abusers.
19 tudy extends this finding to methamphetamine abusers.
20 in cocaine abusers, alcoholics, and heroine abusers.
21 imilar association occurs in methamphetamine abusers.
22 the thalamus and striatum of methamphetamine abusers.
23 s been detected in lymphocyte DNA of alcohol abusers.
24 s, and is prevalent among intravenous opiate abusers.
25 e, on brain glucose metabolism in 20 cocaine abusers.
26 d behavior characteristic of chronic cocaine abusers.
27 al blood donors, and 17% of intravenous drug abusers.
28 ing and relapse in abstinent human substance abusers.
29 to excess during follow-up than did the past abusers.
30 s and the 89 patients who were not substance abusers.
31 rican females and African American substance abusers.
32 tamen of 11 self-identified intravenous drug abusers.
33 ned cocaine abstinence in injecting polydrug abusers.
34 d to facilitate drug abstinence in substance abusers.
35 ession to HAD are accelerated in opiate drug abusers.
36 gic refraction should be done for Smartphone abusers.
37 ary ciliogenesis in the astrocytes of opioid abusers.
38 sm of accommodation is unclear in Smartphone abusers.
39 iously described in ICU patients and alcohol abusers.
40 ated disease observed in HIV-1-infected drug abusers.
41 de to D2/D3 receptors) in detoxified cocaine abusers.
42 larly affected in chronic opioid and cocaine abusers.
43 opride) to MP between controls and marijuana abusers.
44 t this response would be blunted in cannabis abusers.
45 underlie decision-making impairments in drug abusers.
46 matergic and dopaminergic pathways in opiate abusers.
47 maladaptive decision making seen in cocaine abusers.
48 AIDS dementia is accelerated in opiate drug abusers.
49 t peripheral visual field changes in cocaine abusers.
50 rs1137070 was significantly higher in heroin abusers.
51 MAT2 availability in the striatum of cocaine abusers.
52 to relapse and outcome in abstinent cocaine abusers.
53 e been attributed to buprenorphine in opioid abusers.
54 underlying impaired host defense in alcohol abusers.
55 t of reproductive competence in male steroid abusers.
60 iosis in the brains of human methamphetamine abusers, a level of activation that appears to subside o
65 tudy reports on 12 abstinent methamphetamine abusers and 12 age-, gender-, and education-matched cont
69 d 62 participants (43 non-detoxified cocaine abusers and 19 controls) using positron emission tomogra
70 ic distribution of rs1137070 in 1,035 heroin abusers and 2,553 healthy controls and investigated the
76 Depressive disorders are common among opiate abusers and are associated with detrimental behavioral e
77 nous European Caucasian population of heroin abusers and control subjects and in an animal model of h
78 robust allele frequency differences between abusers and controls in both European- and African-Ameri
80 these systems in three populations of opiate abusers and controls, totaling 489 individuals from Euro
82 individuals may be sheltering in place with abusers and facing mounting economic and health-related
83 evelop immune thrombocytopenia than non-drug abusers and have a higher coinfection with hepatitis C v
86 opportunistic infections in intravenous drug abusers and in opioid-medicated postsurgical patients.
90 ed FHC expression and CXCR4 status in opiate abusers and patients with HIV-associated neurocognitive
91 p of depression to alcohol use among cocaine abusers and suggest a need for further studies of the as
92 ared with those of the 109 current substance abusers and the 89 patients who were not substance abuse
93 y rewards of different magnitudes in cocaine abusers and to study its association with motivation and
95 midbrain gene expression in chronic cocaine abusers and well-matched drug-free control subjects usin
97 in the brains of both animals and human drug abusers, and the cellular mechanisms underlying this inj
105 ic, opioid, and serotonergic systems in drug abusers are seen in positron emission tomography scans.
106 ansporters observed in studies of human drug abusers are the result of the neurobiological effects of
110 tomography and [(11)C]raclopride in 16 METH abusers, both after placebo and after challenge with 60
111 should be broadened to include not only the abuser but also those who may be at risk because of thei
112 ave improved treatment outcomes of substance abusers, but have not been widely implemented in communi
113 ficacious in improving outcomes in substance abusers, but these treatments have rarely been implement
116 ng spasm of accommodation between Smartphone abusers compared to non-users (OR = 6.64, 95% CI = 1.73-
117 ntly drug-abstinent (3 months to 2 years) MA abusers compared with 27 nonsubstance-abusing control su
121 ble aspects of addiction, as human substance abusers continue to pursue drugs despite incurring signi
122 es in striatal metabolism in methamphetamine abusers could reflect long-lasting changes in dopamine c
126 eepiness induced by lorazepam in some of the abusers, despite their significantly lower plasma concen
131 rain DA transporters in five methamphetamine abusers evaluated during short abstinence (<6 months) an
133 for whole brain metabolism, methamphetamine abusers exhibited significantly lower metabolism in the
134 underscore the value of screening substance abusers for PTSD, because it can identify a small but su
135 nical significance of lower VMAT2 in cocaine abusers, for example, its relationship to relapse and vu
136 somal markers whose alleles distinguish drug abusers from control individuals in each of two samples,
138 cloplegic nasal ACA at far in the Smartphone abusers group than the non-users group (mean precyclople
141 60 years of age, 18% of the college alcohol abusers had died, 11% were abstinent, 11% were controlle
142 0 years of age, 28% of the core city alcohol abusers had died, 30% were abstinent, 11% were controlle
145 cifically, compared with controls, marijuana abusers had significantly attenuated behavioral ("self-r
151 ubjects, recently detoxified methamphetamine abusers have lower metabolism in the striatum and thalam
152 tomography (PET) imaging studies in cocaine abusers have shown that low dopamine release in the stri
153 be effective in groups of indigent substance abusers, health services must be integrated into the wel
155 m 52 consecutively admitted injecting heroin abusers in a methadone maintenance treatment program.
160 nce of functional changes in methamphetamine abusers in regions other than those innervated by dopami
163 ntly differed significantly from the current abusers in variables involving frequency of drug and alc
164 bsequently committed sexual offences (victim-abusers), in almost all cases with children, mainly outs
165 doses within the range administered by drug abusers induces cerebral microischemia and that these ef
166 ccelerated disease progression among alcohol abusers infected with HCV is clinically well recognized,
167 a synergistic manner, and suggest that METH abusers infected with HIV may be at increased risk for b
168 ed susceptibility to infection among alcohol abusers is a significant but not well-understood problem
169 idence that low striatal DA function in METH abusers is associated with a greater likelihood of relap
171 m seen in this region in the methamphetamine abusers is the result of methamphetamine effects in circ
173 ion in humans that the doses used by cocaine abusers lead to significant blockade of DAT, and that th
174 Mood disturbances in methamphetamine (MA) abusers likely influence drug use, but the neurobiologic
176 erdose of acetaminophen in a chronic alcohol abuser may result in more severe hepatotoxicity than in
178 own to be sites of neurotoxicity in adult MA abusers, may be more vulnerable to prenatal MA exposure
180 (effect size 0.89; P<0.001), but in cocaine abusers methylphenidate's effects did not differ from pl
181 hophysiological changes occurring in cocaine abusers' midbrains should contribute to the development
186 ethamphetamine at dose levels taken by human abusers of the drug leads to dopamine transporter reduct
187 nagement of chronic pain, and chronic heroin abusers, often present with complications such as increa
189 commercial blood donors and intravenous drug abusers, only 1%-3% of the TTV-positive individuals were
190 rain endothelium seen in HIV(+)/cocaine drug abusers paralleled increased CD68 immunostaining compare
192 hese functions, univariate tests showed that abusers performed significantly worse on certain tests o
195 route of administration for human substance abusers, preclinical models that incorporate inhaled exp
197 Cessation of drug use in chronic opiate abusers produces a severe withdrawal syndrome that is hi
198 s in a context in which many live with their abuser, protecting confidentiality when breaches could p
199 erminals) in the striatum of methamphetamine abusers recover with protracted abstinence and that rela
200 eptors during intoxication in active cocaine abusers regardless of cues exposure, which might contrib
203 studies of psychiatric comorbidity in opioid abusers reported rates of comorbidity that far exceeded
204 o, in comparison subjects but not in cocaine abusers, reward-induced improvements in performance were
207 did not differ between groups, the marijuana abusers showed markedly blunted responses when challenge
211 tes, cocaine at doses typically used by drug abusers significantly increased brain glucose metabolism
212 self-reports of depression and anxiety in MA abusers suggest that these regions are involved in affec
213 dopamine neurons of NURR1-deficient cocaine abusers, suggesting that NURR1 plays a critical role in
214 hich replicates previous findings in cocaine abusers, suggests that D2 receptor-mediated dysregulatio
215 the comparison subjects, the methamphetamine abusers tested after protracted abstinence had lower met
216 ) abstinence interval, eight methamphetamine abusers tested only after protracted abstinence, and 11
218 P(ND) was significantly lower in the cocaine abusers than in the comparison subjects in the limbic st
219 11195 binding were higher in methamphetamine abusers than those in control subjects in all brain regi
220 eactivity to the DA stimulation in marijuana abusers that might contribute to their negative emotiona
222 system was used to model the weekend opiate abuser: the nondependent, nonaddicted, and nontolerant p
223 l stimuli may be involved in motivating drug abusers to engage in drug seeking after abstinence.
224 DA transporters predisposes methamphetamine abusers to neurodegenerative disorders such as Parkinson
225 transporters in striatum, in methamphetamine abusers using positron emission tomography and [(11)C]d-
226 hole brain metabolism in the methamphetamine abusers was 14% higher than that of comparison subjects;
228 ous methylphenidate and in 24 of the cocaine abusers, we also compared dopamine increases when methyl
229 of inhibitory control deficits in substance abusers, we examined neural processing characteristics i
230 ecreases in dopamine D2 receptors in cocaine abusers were associated with decreased metabolism in the
233 , the majority of whom were intravenous drug abusers, were analyzed by using PCR with restriction fra
234 prefrontal and parietal cortices in cocaine abusers when compared with controls, which might reflect
235 the orbitofrontal cortex in methamphetamine abusers, which replicates previous findings in cocaine a
236 XCR4 and exacerbate neuropathology in opiate abusers who are affected by neuroinflammatory/infectious
238 subjects; this reduction was evident even in abusers who had been detoxified for at least 11 months.
240 F]fluorodeoxyglucose in five methamphetamine abusers who were evaluated after both a short (<6 months
241 secondary prevention defibrillators in drug abusers with chronic systolic heart failure is both sens
245 ine at time of study (as compared to cocaine abusers with negative urines) suggesting that the defici
246 widely prescribed for the treatment of drug abusers with opioid dependence, affects human immunodefi
247 bnormalities were accentuated in the cocaine abusers with positive urines for cocaine at time of stud
248 ranulocytopenia frequently occurs in alcohol abusers with severe bacterial infection, which strongly
251 8 participants (24 controls and 24 marijuana abusers) with methylphenidate (MP), a drug that elevates
252 logical deficits commonly afflicting cocaine abusers, yet the underlying mechanisms responsible for t